Global Head Clinical Pharmacology & Pharmacometrics
Johnson & Johnson
Daniele Ouellet, PhD, is Vice President, Global Head of Clinical Pharmacology & Pharmacometrics (CPP), Quantitative Sciences, at Janssen (Johnson & Johnson) where she leads the global team of clinical pharmacologists, pharmacometricians, and the Phase 1 Clinical Pharmacology Unit. Daniele has more than 25 years’ experience in the pharmaceutical industry and has been a champion of quantitative clinical pharmacology approaches throughout her career. In her role at Janssen, she ensures that CPP provides end-to-end clinical pharmacology and PK/PD modeling expertise, starting at first-in-human (FIH) study to registration, to clinical drug development projects for small and large molecules across all Janssen Therapeutic Areas. Prior to her role at Janssen, Daniele was Vice President and Global Head of Pharmacometrics at Pfizer, and previously worked at GlaxoSmithKline, Parke-Davis (Pfizer), Phoenix Intl Life Sciences, and Abbott Labs. Daniele has a BPharm degree from the University of Montreal and graduated with a MS and PhD degrees from the University of North Carolina at Chapel Hill.
Daniele is currently serving on the Board of Directors of the American Society of Clinical Pharmacology and Therapeutics (ASCPT) and of the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ). She is a fellow of the International Society of Pharmacometrics (ISoP), was awarded the ISoP Leadership Award in November 2020, and served on their board of directors (2014-2017). Daniele has published more than 65 original articles, multiple abstracts, and served as a peer reviewer for different journals.
Disclosure information not submitted.
Tuesday, January 11, 2022
9:55 AM – 10:00 AM ET
Tuesday, January 11, 2022
10:00 AM – 11:00 AM ET
Tuesday, January 11, 2022
4:45 PM – 5:00 PM ET
Tuesday, January 11, 2022
5:05 PM – 5:35 PM ET
Wednesday, March 16, 2022
6:00 PM – 6:15 PM ET
Friday, March 18, 2022
1:15 PM – 2:15 PM ET
Friday, March 18, 2022
2:30 PM – 3:30 PM ET